References
- Riott I. M. Hypersensitivity in Essential Immunology, I. M. Riott. BLackwell Scientific Publications, Oxford 1994; 312–336
- Hirata Y. Autoimmune insulin syndrome “up to date”. Hypoglycemia, D. Andreani, V. Marks, P. J. Lefevre. Raven Press, New York 1987; 105–118
- Redmon B., Pyzdrowski K., Elson M. K., Kay N. E., Dalmasso A. P., Nuttall F. Q. Hypoglycemia due to a monoclonal insulin-binding antibody in multiple myeloma. N. Engl. J. Med. 1992; 326: 994–998
- Eguchi Y., Uchigata Y., Yao K., et al. Longitudinal changes of serum insulin concentration and insulin antibody features in insulin autoimmune syndrome (Hirata' Disease). Autoimmunity
- Uchigata Y., Kuwata S., Tokunaga K., Eguchi Y., Takayama-Hasumi S., Miyamoto M., Omori Y., Hirata Y. Strong association of insulin autoimmune syndrome with HLA-DR4. Lancet 1992; 339: 393–394
- Uchigata Y., Omori Y., Neieda M., Kuwata S., Tokunaga K., Juji T. HLA-genotype and insulin-processing in insulin autoimmune syndrome. Lancet 1992; 340: 1467
- Uchigata Y., Tokunaga K., et al. Differential immuno-genetic determinants of polyclonal IAS (Hirata' Disease) and monoclonal IAS. Diabetes
- Ito Y., Nieda M., Uchigata Y., Nishimura M., Tokunaga K., Kuwata S., Obata F., Tadokoro K., Hirata Y., Omori Y., Juji T. Recognition of human insulin in the context of HLA-DRB 1*0406 products by T cells of insulin autoimmune syndrome patients and healthy donors. J. Immunol. 1993; 151: 5770–5776
- Matsushita S., Takahashi K., Motoki M., Komoriya K., Ikagawa S., Nishimura Y. Allele specificity of structural requirement for peptides bound to HLA-DRB 1*0405 and-DRB1*0406 complexes: Implication for the HLA associated susceptibility to methimazole-induced insulin autoimmune syndrome. J. Exp. Med. 1994; 180: 873–883
- Uchigata Y., Eguchi Y., Hasumi S., Omori Y. Insulin autoimmune syndrome (Hirata's disease): Clinical features and epidemiology in Japan. Diabetes Res. Clin. Prac. 1994; 22: 89–94